HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts

HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts

Posted by Adam Awdish on

Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following study:

 

HLA DRB1*15:01-DQB1*06:02-Restricted Human CD4+ T-Cells are Selectively Activated with Amoxicillin-Peptide Adducts

Arun Tailor, Xiaoli Meng, Kareena Adair, John Farrell, James C Waddington, Ann Daly, Munir Pirmohamed, Gordon Dear, B Kevin Park, Dean J Naisbitt

Toxicological Sciences
August 10, 2020

Idiosyncratic drug-induced liver injury (DILI) is a major health concern often associated with a high patient death rate. Amoxicillin-clavulanate is the most common cause of DILI, and the detection of drug-specific CD4+ T-cells in patients with DILI suggests it originates somewhere in the immune system. Researchers in this study aimed to (1) investigate whether amoxicillin-modified HLA-DRB1*15:01-DQB1*06:02 binding peptides selectively activate DILI patient T-cells and (2) define the nature of the T-cell response with respective to antigen structure.

The researchers were able to generate Amoxicillin-modified peptides and then purified and characterized them using mass spectrometry. Next, key fragment ions derived from the cleavage of the peptide backbone were identified for each modified peptide to distinguish positional derivatives and the amoxicillin peak. Researchers then analyzed each batch of peptides in order to quantify unbound amoxicillin. The amoxicillin-modified peptides were found to contain approximately 2-3% unbound amoxicillin, which is well below the concentration of amoxicillin that scientists have previously shown could activate T-cells (8µM).

 

Related products available from Innovative Research also include:

Pooled Human Serum Off The Clot

Pooled Human Complement Serum

Pooled Human Plasma (Blood Derived)

  • Tags: Human Serum, Pooled Human AB Serum Plasma Derived

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    A Proof-of-Concept, Two-Tiered Approach for Ricin Detection Using Ambient Mass Spectrometry
    Single Donor Human Urine and Single Donor Human Serum Off The Clot from Innovative Rese...
    Read the Article

    ← Older Post Newer Post →